Cure My Disease

Don't miss your cure!

 Log in / Sign up

Group emotion regulation therapy put to the test for teen self-harm

NCT ID NCT07720063

Disease control Sponsor: Karolinska Institutet Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 22, 2026 · Last updated Aug 19, 2026 · Updated 3 times

Summary

This trial tests whether a 12-week group therapy program called Emotion Regulation for Adolescents (ERA) can reduce non-suicidal self-injury in teens aged 13 to 17. Participants must have self-harmed at least five times in the past year, including once in the past month. The program teaches skills to manage difficult emotions and reduce impulsive behaviors, with a separate parent group. The study compares ERA to an active control condition to see if it works better than standard support.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a 12-week manualized group emotion regulation therapy (ERA) plus a parallel 5-session parent program
What this could lead to
If effective, ERA could provide a brief, scalable group treatment for adolescent self-harm within routine mental health services.
What could go wrong
This is a relatively early-stage trial with 180 participants; the active control condition may also reduce self-harm, making it hard to show a clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2034

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 13 - 17 years * At least 5 instances of NSSI in the past year, and at least one during the past month * ≥5 episodes of NSSI in the past year, including ≥1 in the past month * If receiving antidepressant, central stimulants or neuroleptic medication, dose must be stable for least 6 weeks prior to inclusion * At least one participating caregiver * Sufficient Swedish language proficiency (adolescent and caregiver) * Regular access to a smartphone for SMS-based assessment Exclusion Criteria: * Intellectual disability or a severe psychiatric disorder requiring immediate treatment (e.g., psychosis, bipolar disorder type 1, anorexia nervosa, alcohol/substance dependence) or conditions that prevent participation (e.g., severe social anxiety, selective mutism) * Acute suicide risk (i.e., current suicide plans) or recent suicide attempt * Previous or ongoing structured emotion regulation treatment involving at least 3 sessions during the past 12 months * Previous or ongoing structured emotion regulation treatment (≥3 sessions within past 12 months) * Social circumstances preventing participation or require immediate action (e.g., domestic violence, abuse and/or neglect in the family, inpatient care) * Ongoing structured psychological treatment targeting NSSI

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Non suicidal self injury are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Self-Injurious Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Non suicidal self injury Non-suicidal self-injury (NSSI) Self-harm Self-harm behavior Self-harm, deliberate

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.